Carmignac Gestion’s Vigil Neuroscience VIGL Stock Holding History

Carmignac Gestion’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-241,755	Closed	-$1.92M	–	163
2025 Q2	$1.92M	Buy	+241,755	New	+$1.08M	0.03%	100

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Carmignac Gestion's VIGL Position: Q3 2025 in Review

Carmignac Gestion sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 241,755 shares — an estimated $1.92M sold.

Carmignac Gestion first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $1.92M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Carmignac Gestion reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Carmignac Gestion sold 241,755 Vigil Neuroscience shares in Q3 2025, an estimated $1.92M.
Carmignac Gestion first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Carmignac Gestion's Vigil Neuroscience position peaked at $1.92M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Carmignac Gestion's 13F filing for Q3 2025, filed 13 Nov 2025.